Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mallik Greene, Chakkarin Burudpakdee, Arpamas Seetasith, Michael Behling & Holly Krasa. (2019) Evaluation of patient support program and adherence to long-acting injectable aripiprazole for patients utilizing injection local care centers. Current Medical Research and Opinion 35:1, pages 97-103.
Read now
Read now
Articles from other publishers (13)
Sara H Browne, Florin Vaida, Anya Umlauf, Amanda J Tucker, Terrence F Blaschke & Constance A Benson. (2023) Supporting the Art: Medication Adherence Patterns in Persons Prescribed Ingestible Sensor-enabled Oral Pre-Exposure Prophylaxis to Prevent Human Immunodeficiency Virus Infection. Clinical Infectious Diseases 76:1, pages 134-143.
Crossref
Crossref
Jie Liu, Victoria Sheets, Rachel Maerz, Ai Ni, Ulysses Magalang, Ching-Chang Ko & Allen Firestone. (2022) A multifactorial intervention to increase adherence to oral appliance therapy with a titratable mandibular advancement device for obstructive sleep apnea: a randomized controlled trial. Sleep and Breathing 26:4, pages 1739-1745.
Crossref
Crossref
José Antonio Sacristán, Esther Artime, Silvia Díaz-Cerezo, Marta Comellas, Lucía Pérez-Carbonell & Luis Lizán. (2022) The Impact of Patient Support Programs in Europe: A Systematic Literature Review. The Patient - Patient-Centered Outcomes Research 15:6, pages 641-654.
Crossref
Crossref
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatríz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Elke Theander & Josef S Smolen. (2022) Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study. Annals of the Rheumatic Diseases 81:6, pages 823-830.
Crossref
Crossref
Irene Lizano-Díez, Sonia Amaral-Rohter, Lucía Pérez-Carbonell & Susana Aceituno. (2021) Impact of Home Care Services on Patient and Economic Outcomes: A Targeted Review. Home Health Care Management & Practice 34:2, pages 148-162.
Crossref
Crossref
Kevin V. Carlson, Eric S. Rovner, Kavita V. Nair, Anna S. Deal, Rita M. Kristy & John C. Hairston. (2021)
Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the
PERSPECTIVE
registry study
. LUTS: Lower Urinary Tract Symptoms 13:4, pages 425-434.
Crossref
Crossref
Aimee M. Near, Chakkarin Burudpakdee, Shilpa Viswanathan & Shuchita Kaila. (2021) Effect of a Patient Support Program for Idiopathic Pulmonary Fibrosis Patients on Medication Persistence: A Retrospective Database Analysis. Advances in Therapy 38:7, pages 3888-3899.
Crossref
Crossref
Neeraj Narula, Brad Millson, Katia Charland, Krishna Donepudi, Tania Gaetano, Kevin McHugh, Martin G Latour, Sandra Gazel, Marie-Claude Laliberté & John K Marshall. (2018) Impact of Adalimumab Patient Support Program’s Care Coach Calls on Clinical
Outcomes in Patients with Crohn’s Disease in Canada: An Observational Retrospective Cohort
Study. Journal of the Canadian Association of Gastroenterology 1:4, pages 191-198.
Crossref
Crossref
Fang Liz Zhou, Jason Yeaw, Swapna U Karkare, Mitch DeKoven, Paulos Berhanu & Timothy Reid. (2018) Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes. BMJ Open Diabetes Research & Care 6:1, pages e000593.
Crossref
Crossref
John K. Marshall, Louis Bessette, Neil H. Shear, Gerald Lebovic, Jennifer Glass, Brad Millson, Tania Gaetano, Sandra Gazel, Martin G. Latour, Marie-Claude Laliberté & J. Carter Thorne. (2018) Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study. Clinical Therapeutics 40:6, pages 1024-1032.
Crossref
Crossref
Einav Srulovici, Vishvas Garg, Adi Ghilai, Becca Feldman, Moshe Hoshen, Ran D. Balicer, Martha Skup & Maya Leventer-Roberts. (2018) Is Patient Support Program Participation Associated with Longer Persistence and Improved Adherence Among New Users of Adalimumab? A Retrospective Cohort Study. Advances in Therapy 35:5, pages 655-665.
Crossref
Crossref
Filip Van den Bosch, Andrew J. K. Ostor, Siegfried Wassenberg, Naijun Chen, Chen Wang, Vishvas Garg & Jasmina Kalabic. (2017) Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study. Rheumatology and Therapy 4:1, pages 85-96.
Crossref
Crossref
Leslie R. Harrold, Bradley S. Stolshek, Sabrina Rebello, David H. Collier, Alex Mutebi, Sally W. Wade, Wendi Malley, Jeffrey D. Greenberg & Carol J. Etzel. (2017) Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry. Clinical Rheumatology 36:4, pages 895-901.
Crossref
Crossref